Cart
sales@molnova.com
Pseudolaric Acid C2
CAS No. 82508-35-8
Pseudolaric Acid C2( —— )
Catalog No. M22829 CAS No. 82508-35-8
Pseudolaric Acid C2 is a diterpenoid isolated from Pseudolarix kaempferi.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 159 | In Stock |
|
| 5MG | 144 | In Stock |
|
| 10MG | 235 | In Stock |
|
| 25MG | 397 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePseudolaric Acid C2
-
NoteResearch use only, not for human use.
-
Brief DescriptionPseudolaric Acid C2 is a diterpenoid isolated from Pseudolarix kaempferi.
-
DescriptionPseudolaric Acid C2 is a diterpenoid isolated from Pseudolarix kaempferi.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number82508-35-8
-
Formula Weight418.44
-
Molecular FormulaC22H26O8
-
Purity>98% (HPLC)
-
SolubilityNA
-
SMILESCC(O[C@]12[C@@]3(CC=C(C(O)=O)CC2)C(O[C@@](/C=C/C=C(C)/C(O)=O)(C)[C@]1([H])CC3)=O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Liu P, et al. Simultaneous determination of seven major diterpenoids in Pseudolarix kaempferi by high-performance liquid chromatography DAD method. J Pharm Biomed Anal. 2007 Jul 27;44(3):730-6.
molnova catalog
related products
-
[Pyr5]-Substance P (...
[Glp5] Substance P (5-11) is an octapeptide. [Glp5] Substance P (5-11) is one of the main substance P fragments in rat central nervous system (CNS). [Glp5] Substance P (5-11) locally modulates dopamine release in rat striatum.
-
4-Chlorocatechol
4-Chlorocatechol is a major degradation product of 4-chloro-2-aminophenol (4C2AP). 4-Chlorocatechol is also a substrate for catechol 1,2-dioxygenases and chlorocatechol dioxygenase.
-
C-Reactive Protein (...
CRP, an acute phase serum protein synthesized in response to inflammatory cytokines, produces antitumor effects in animals. The fragment CRP (174-185) (RS-83277) shows similar activity by significantly enhancing the tumoricidal activity of human monocytes and alveolar macrophages in vitro.
